Parkinson's disease (PD) is a neurodegenerative disorder primarily affecting the motor system. As healthcare professionals, a comprehensive understanding of PD is essential for effective diagnosis and management.
The exact cause of PD remains unknown. However, it is widely accepted that a combination of genetic and environmental factors plays a significant role. The disease is characterized by the death of dopamine-producing neurons in the substantia nigra, a region in the midbrain, leading to a dopamine deficiency.
PD typically presents with motor symptoms such as bradykinesia, resting tremor, and rigidity. Non-motor symptoms, including autonomic dysfunction, cognitive impairment, and mood disorders, may also be present. The progression of symptoms varies widely among patients.
PD is primarily diagnosed based on clinical criteria, including the presence of bradykinesia and either resting tremor or rigidity. Neuroimaging techniques, such as DaTSCAN, can support the diagnosis, but they are not routinely used due to their high cost and limited availability.
Management of PD focuses on symptomatic treatment. Pharmacotherapy, including levodopa and dopamine agonists, is the mainstay of treatment. Non-pharmacological approaches such as physiotherapy and occupational therapy also play a crucial role. In advanced stages, deep brain stimulation may be considered.
PD is a complex neurodegenerative disorder with a multifaceted clinical presentation. Understanding its etiology, recognizing its symptoms, and being familiar with the current diagnostic and treatment strategies are key to providing optimal care for patients with PD. As we continue to delve deeper into the intricacies of this disease, we can hope to improve both the quality of life and lifespan of those affected.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation